Epigenomics AG / Key word(s): Regulatory Admission 04.11.2015 20:19 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— FDA requests further data for approval of Epigenomics’ blood-based colorectal cancer screening test […]
Year: 2015
04. November 2015
Epigenomics AG: FDA requests further data for approval of Epigenomics’ blood-based colorectal cancer screening test
Read more
04. November 2015
Epigenomics AG: Epigenomics adjusts 2015 outlook after FDA response letter
Epigenomics AG / Key word(s): Miscellaneous 04.11.2015 20:30 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Epigenomics adjusts 2015 outlook after FDA response letter Berlin, Germany, November 4, 2015 – […]
04. November 2015
Epigenomics AG: FDA requests further data for approval of Epigenomics’ blood based colorectal cancer screening test
DGAP-News: Epigenomics AG / Key word(s): Regulatory Admission 2015-11-04 / 20:30 Press release FDA requests further data for approval of Epigenomics’ blood based colorectal cancer screening test FDA provides recommendations for amending the application in order to make it approvable Further study on increased compliance and adherence of Epi proColon(R) expected Strategic commercialization partner Polymedco […]
02. November 2015
Epigenomics AG: Epigenomics AG to provide an update on blood-based epigenetic tests at the Association of Molecular Pathology (AMP) 2015 Annual Meeting
DGAP-News: Epigenomics AG / Key word(s): Conference 2015-11-02 / 14:00 Press release Epigenomics AG to provide an update on blood-based epigenetic tests at the Association of Molecular Pathology (AMP) 2015 Annual Meeting Berlin (Germany) and Germantown, MD (U.S.A.), November 2, 2015 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics […]
30. October 2015
Epigenomics AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AG / Veröffentlichung der Gesamtzahl der Stimmrechte 30.10.2015 18:15 Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG, übermittelt durch DGAP – ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. ————————————————————————— Hiermit teilt die Epigenomics AG mit, dass die Gesamtzahl der Stimmrechte am Ende des Monats Oktober […]
09. September 2015
Epigenomics AG: Release of Voting Rights Notifications (§ 21 para. 1 WpHG)
Epigenomics AG 09.09.2015 17:02 Dissemination of a Voting Rights Announcement, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Voting Rights: Release of Voting Rights Notifications (§ 21 para. 1 WpHG) in Accordance with § 26 para. 1 WpHG (German Securities Trading […]